262 related articles for article (PubMed ID: 5344299)
1. [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
Birkmayer W
Wien Klin Wochenschr; 1969 Sep; 81(39):677-9. PubMed ID: 5344299
[No Abstract] [Full Text] [Related]
2. [Effect of the combined treatment of Parkinson patients with L-Dopa and a decarboxylase inhibitor (Ro4-4602). Quantitative analysis of bradykinesia by means of reaction time measurements].
Kaufmann W; Butz P; Wiesendanger M
Dtsch Z Nervenheilkd; 1970; 197(1):85-100. PubMed ID: 5522871
[No Abstract] [Full Text] [Related]
3. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Kaufmann W; Butz P; Wiesendanger M
Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J; Klaiber R; Perret E; Ziegler WH
Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
6. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
7. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Birkmayer W; Linauer W; Mentasti M; Riederer P
Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
[No Abstract] [Full Text] [Related]
8. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
De Divitiis E; Cerillo A; Tata MR; Decina A
Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
[No Abstract] [Full Text] [Related]
9. [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
Völler GW; Muschard F
Med Welt; 1973 Apr; 24(17):705-7. PubMed ID: 4750934
[No Abstract] [Full Text] [Related]
10. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
11. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Gattringer B; Steinhäusl H
Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
[No Abstract] [Full Text] [Related]
12. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
13. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
[No Abstract] [Full Text] [Related]
14. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
[No Abstract] [Full Text] [Related]
15. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
16. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Görlich J; Markus E
Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
[No Abstract] [Full Text] [Related]
17. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Streifler M; Vardi J; Kesten M
Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737
[No Abstract] [Full Text] [Related]
18. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)].
Gehlen W; Eisenlohr JJ
Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993
[No Abstract] [Full Text] [Related]
19. [Modalities of treatment of Parkinsonian syndrome with L-dopa].
Yanniotis G; Eisenring JJ; Gauthier G; Tissot R; de Ajuriaguerra J
Int J Neurol; 1972; 9(1):23-32. PubMed ID: 5086635
[No Abstract] [Full Text] [Related]
20. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
Lombardo L; de la Garza R; Ivan-Reynoso G
Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
